who makes retatrutide Retatrutide? Company Behind the Weight Loss Drug Exciting News! 🗞️ Retatrutide is

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers

Because GLP-1 also has potential anti-inflammatory properties, it can contribute to a healthier gut lining, thus preventing gastrointestinal problems in the long term

The Bristol Stool Chart is often used by doctors to assess whether your poop is healthy or youre having health issues like constipation, diarrhea, or an underlying condition.

As GLP-1 medications curb alcohol cravings for millions and public health agencies tighten their guidance, moderate wine drinkers are left sorting through headlines, half-truths, and evolving science

MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation, and despite strong third-quarter performances from many firms in this sector